Skip to content

The Seibold Lab is focused on identifying genetic determinants and biomarkers of complex lung diseases, including asthma and pulmonary fibrosis. Many of the genetic variants that influence development and severity of these lung diseases do so by altering molecular functions in specific lung cell types. His lab is focused on identifying dysregulated molecular functions in patient lung cells, by Nex-Generation sequencing technologies. Using patient cohorts the genetic determinants of these molecular changes are then mapped. The lab is also editing the genome of these lung cells to allow detailed mechanistic studies of disease variants and better understanding of how these genetic changes increase risk of disease development.

The Seibold Lab is currently seeking students and post-doctoral fellows to be part of a collaborative team working to identify genetic determinants of complex lung diseases through the use of genetic epidemiology and molecular genetics.


Current Projects

  1. Nasal Airway Epithelia Expression Genetics and Epigenetics in Puerto Rican Asthmatics.

  2. Functional characterization of an IPF genetic risk variant.

  3. Genomic editing of primary lung cells.

  4. Genetics of expression in asthmatic bronchial epithelium

Max Seibold

Max Seibold, PhD


Max A. Seibold, PhD

Elmar Pruesse, PhD Bioinformatics Software Engineer

Nathan Jackson, PhD Senior Bioinformatics Analyst

Megha Suswaram, PhD. Biostatistician

Elizabeth Secor, MA Biostatistician

Jamie Everman, PhD Faculty Scientist

Yingchun Li, MD PhD Faculty Scientist

Katrina Diener, Lab Manager

Zoe Stewart, Senior Lab Researcher Genomics

Ana Fairbanks-Mahnke, Lab Researcher Genomics

Gianna Zinnen, Lab Researcher Genomics

Caleb Gammon, Student Researcher/Intern

Max H. Seibold, Student Researcher/Intern

Ashley Naughton, Coordinator


Contact Information

Dr. Max A. Seibold
Office: 303.270.2544
Lab: 303.270.2650

More Information

For more information about the Seibold Laboratory click here



Interleukin-13 associated epithelial remodeling correlates with clinical severity in nasal polyposis.
Kotas ME, Patel NN, Cope EK, Gurrola JG 2nd, Goldberg AN, Pletcher SD, Seibold MA, Moore CM, Gordon ED.J Allergy Clin Immunol. 2023 Feb 1:S0091-6749(23)00141-0. doi: 10.1016/j.jaci.2022.12.826. Online ahead of print.PMID: 36736797 

More Publications